Microbot Medical Inc. (MBOT)

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close

1.07 on 9 Oct 2026

0 buys0 sales at will0 planned sales

Fiscal year 2025, ended 31 Dec 2025, as filed

Net income

$13.14M

Free cash flow

$13.11M

Return on equity

-17.0%

Return on capital

-15.0%

Fiscal years, as filed with the SEC · point at a year for the detail

RevenueNet incomeLoss

From Form 4, most recent first

Date	Insider	Type	Value	Of own stake
19 Oct 2020	Bornstein Yoseph Director	Sold, plan not stated	$38.73K	2.0%
5 Oct 2020	Bornstein Yoseph Director	Sold, plan not stated	$311.75K	13.9%
17 Aug 2020	Bornstein Yoseph Director	Sold, plan not stated	$154.09K	5.0%
23 Dec 2019	Gadot Harel Chairman, President and CEO	Sold, plan not stated	$400.00K	22.6%
9 Jan 2018	Bornstein Yoseph Director	Sold, plan not stated	$37.19K	0.8%
3 Jan 2018	Bornstein Yoseph Director	Sold, plan not stated	$2.88K	0.1%

37out of 100

Profitability 0

Financial strength 70

Growth n/a

Insiders 50

Strongest on financial strength (70), weakest on profitability (0). A score of the business, not of the price.

Last 12 months

Only here

Bought

$0.00

0 buys, 0 buyers

Sold

$0.00

0 sales

Planned sales

n/a

under a 10b5-1 plan